<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0053568-Khurana3">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Khurana</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Larkin</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Verma</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Joshi</surname>
   <given-names>MB</given-names>
  </name>, 
  <name>
   <surname>Fontana</surname>
   <given-names>J</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2011</year>) 
  <article-title>Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines</article-title>. 
  <source>Vaccine</source>
  <volume>29</volume>: 
  <fpage>5657</fpage>â€“
  <lpage>5665</lpage>.
  <pub-id pub-id-type="pmid">21704111</pub-id>
 </mixed-citation>
</ref>
